Founded in 2005 by two scientists from the American pharmaceuticals giant Merck — Stephen Gallagher, 47, and Alastair Hill, 43 — Dotmatics develops software supporting new drug research and materials innovation. During the pandemic, its cloud-based technology has enabled scientists to work remotely by giving them real-time access to project data, as well as analytics and data visualisation tools. Offices in the US, Japan and South Korea helped overseas sales reach £21.7 million in 2019.
This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.
